发明申请
US20110312968A1 METHOD FOR OPTIMIZING THE TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH ABL TYROSINE KINASE INHIBITORS
审中-公开
用ABL酪氨酸激酶抑制剂优化治疗慢性粒细胞白血病的方法
- 专利标题： METHOD FOR OPTIMIZING THE TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH ABL TYROSINE KINASE INHIBITORS
- 专利标题（中）： 用ABL酪氨酸激酶抑制剂优化治疗慢性粒细胞白血病的方法
-
申请号： US13126683申请日： 2009-11-05
-
公开(公告)号： US20110312968A1公开(公告)日： 2011-12-22
- 发明人: Nicola Esposito , Barbara Izzo , Thea Kalebic , Fabrizio Pane , Fabrizio Quarantelli
- 申请人： Nicola Esposito , Barbara Izzo , Thea Kalebic , Fabrizio Pane , Fabrizio Quarantelli
- 国际申请： PCT/US09/63349 WO 20091105
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; A61P35/02 ; C12Q1/68
摘要：
The present invention relates to a method tor evaluating patterns to help-optimizing the treatment of chronic myeloid leukemia (CML) in a human patient population. Specifically, present invention relates to SHP1 and/or SHP2 as a biomarker for CML patients.